LifeMD (LFMD) Stock Price
LifeMD Price
Revenue has compounded at 43.9% per year over the past 14 years to 212.45 M USD. LifeMD's net margin stands at -10.3%, up from -170.0% several years earlier. Analysts set a median price target of 8.67 USD, implying 108.9% above the current price. Of 14 analysts, 12 rate the stock a buy — an overall Buy consensus. The stock trades about 57% above its 52-week low.
LifeMD stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of LifeMD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how LifeMD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing LifeMD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | LifeMD Price |
|---|---|
| 7/17/2026 | 4.15 USD |
| 7/16/2026 | 4.50 USD |
| 7/15/2026 | 4.53 USD |
| 7/14/2026 | 4.51 USD |
| 7/13/2026 | 4.79 USD |
| 7/10/2026 | 4.64 USD |
| 7/9/2026 | 4.73 USD |
| 7/8/2026 | 4.65 USD |
| 7/7/2026 | 4.88 USD |
| 7/6/2026 | 4.93 USD |
| 7/2/2026 | 4.87 USD |
| 7/1/2026 | 4.54 USD |
| 6/30/2026 | 4.13 USD |
| 6/29/2026 | 4.20 USD |
| 6/26/2026 | 4.13 USD |
| 6/25/2026 | 4.20 USD |
| 6/24/2026 | 4.50 USD |
| 6/23/2026 | 4.55 USD |
| 6/22/2026 | 4.58 USD |
| 6/18/2026 | 4.75 USD |
| 6/17/2026 | 4.91 USD |
| 6/16/2026 | 4.82 USD |
| 6/15/2026 | 4.91 USD |
| 6/12/2026 | 4.70 USD |
| 6/11/2026 | 4.90 USD |
| 6/10/2026 | 4.97 USD |
| 6/9/2026 | 4.82 USD |
| 6/8/2026 | 5.02 USD |
| 6/5/2026 | 4.89 USD |
| 6/4/2026 | 4.87 USD |
| 6/3/2026 | 4.56 USD |
| 6/2/2026 | 4.69 USD |
| 6/1/2026 | 4.63 USD |
| 5/29/2026 | 4.28 USD |
| 5/28/2026 | 4.59 USD |
| 5/27/2026 | 4.57 USD |
| 5/26/2026 | 4.24 USD |
| 5/22/2026 | 4.19 USD |
| 5/21/2026 | 4.07 USD |
| 5/20/2026 | 4.26 USD |
| 5/19/2026 | 4.30 USD |
| 5/18/2026 | 4.24 USD |
| 5/15/2026 | 4.33 USD |
| 5/14/2026 | 4.48 USD |
| 5/13/2026 | 4.54 USD |
| 5/12/2026 | 4.28 USD |
| 5/11/2026 | 4.39 USD |
| 5/8/2026 | 4.78 USD |
| 5/7/2026 | 4.49 USD |
| 5/6/2026 | 5.27 USD |
| 5/5/2026 | 5.13 USD |
| 5/4/2026 | 5.09 USD |
| 5/1/2026 | 5.00 USD |
| 4/30/2026 | 4.68 USD |
| 4/29/2026 | 4.43 USD |
| 4/28/2026 | 4.55 USD |
| 4/27/2026 | 4.57 USD |
| 4/24/2026 | 4.64 USD |
| 4/23/2026 | 4.73 USD |
| 4/22/2026 | 4.62 USD |
| 4/21/2026 | 4.53 USD |
| 4/20/2026 | 5.06 USD |
| 4/17/2026 | 4.09 USD |
| 4/16/2026 | 3.94 USD |
| 4/15/2026 | 3.83 USD |
| 4/14/2026 | 3.77 USD |
| 4/13/2026 | 3.91 USD |
| 4/10/2026 | 3.47 USD |
| 4/9/2026 | 3.40 USD |
| 4/8/2026 | 3.47 USD |
| 4/7/2026 | 3.43 USD |
| 4/6/2026 | 3.58 USD |
| 4/2/2026 | 3.51 USD |
| 4/1/2026 | 3.58 USD |
| 3/31/2026 | 3.61 USD |
| 3/30/2026 | 3.60 USD |
| 3/27/2026 | 3.72 USD |
| 3/26/2026 | 3.94 USD |
| 3/25/2026 | 3.90 USD |
| 3/24/2026 | 3.88 USD |
| 3/23/2026 | 3.98 USD |
| 3/20/2026 | 3.90 USD |
| 3/19/2026 | 4.09 USD |
| 3/18/2026 | 4.11 USD |
| 3/17/2026 | 4.44 USD |
| 3/16/2026 | 4.40 USD |
| 3/13/2026 | 3.98 USD |
| 3/12/2026 | 3.94 USD |
| 3/11/2026 | 4.06 USD |
| 3/10/2026 | 3.91 USD |
| 3/9/2026 | 3.12 USD |
| 3/6/2026 | 3.00 USD |
| 3/5/2026 | 3.00 USD |
| 3/4/2026 | 3.12 USD |
| 3/3/2026 | 2.91 USD |
| 3/2/2026 | 2.91 USD |
| 2/27/2026 | 2.67 USD |
| 2/26/2026 | 2.78 USD |
| 2/25/2026 | 2.76 USD |
| 2/24/2026 | 2.67 USD |
| 2/23/2026 | 2.64 USD |
| 2/20/2026 | 2.82 USD |
| 2/19/2026 | 2.90 USD |
| 2/18/2026 | 2.95 USD |
| 2/17/2026 | 2.85 USD |
| 2/13/2026 | 2.78 USD |
| 2/12/2026 | 2.80 USD |
| 2/11/2026 | 2.91 USD |
| 2/10/2026 | 3.05 USD |
| 2/9/2026 | 3.20 USD |
| 2/6/2026 | 3.14 USD |
| 2/5/2026 | 2.77 USD |
| 2/4/2026 | 3.07 USD |
| 2/3/2026 | 3.18 USD |
| 2/2/2026 | 3.28 USD |
| 1/30/2026 | 3.24 USD |
| 1/29/2026 | 3.37 USD |
| 1/28/2026 | 3.40 USD |
| 1/27/2026 | 3.50 USD |
| 1/26/2026 | 3.52 USD |
| 1/23/2026 | 3.58 USD |
| 1/22/2026 | 3.62 USD |
| 1/21/2026 | 3.54 USD |
| 1/20/2026 | 3.56 USD |
| 1/16/2026 | 3.77 USD |
| 1/15/2026 | 3.77 USD |
| 1/14/2026 | 3.85 USD |
| 1/13/2026 | 3.98 USD |
| 1/12/2026 | 4.19 USD |
| 1/9/2026 | 3.86 USD |
| 1/8/2026 | 4.00 USD |
| 1/7/2026 | 3.93 USD |
| 1/6/2026 | 4.22 USD |
| 1/5/2026 | 3.91 USD |
| 1/2/2026 | 3.49 USD |
| 12/31/2025 | 3.41 USD |
| 12/30/2025 | 3.49 USD |
| 12/29/2025 | 3.44 USD |
| 12/26/2025 | 3.50 USD |
| 12/24/2025 | 4.00 USD |
| 12/23/2025 | 3.46 USD |
| 12/22/2025 | 3.20 USD |
| 12/19/2025 | 3.23 USD |
| 12/18/2025 | 3.24 USD |
| 12/17/2025 | 3.24 USD |
| 12/16/2025 | 3.42 USD |
| 12/15/2025 | 3.27 USD |
| 12/12/2025 | 3.40 USD |
| 12/11/2025 | 3.46 USD |
| 12/10/2025 | 3.61 USD |
| 12/9/2025 | 3.63 USD |
| 12/8/2025 | 3.64 USD |
| 12/5/2025 | 3.50 USD |
| 12/4/2025 | 3.73 USD |
| 12/3/2025 | 3.72 USD |
| 12/2/2025 | 3.56 USD |
| 12/1/2025 | 3.57 USD |
| 11/28/2025 | 3.83 USD |
| 11/26/2025 | 3.84 USD |
| 11/25/2025 | 3.93 USD |
| 11/24/2025 | 3.97 USD |
| 11/21/2025 | 3.85 USD |
| 11/20/2025 | 3.71 USD |
| 11/19/2025 | 3.99 USD |
| 11/18/2025 | 4.09 USD |
| 11/17/2025 | 4.73 USD |
| 11/14/2025 | 4.63 USD |
| 11/13/2025 | 4.62 USD |
| 11/12/2025 | 5.07 USD |
| 11/11/2025 | 5.06 USD |
| 11/10/2025 | 5.13 USD |
| 11/7/2025 | 5.24 USD |
| 11/6/2025 | 5.26 USD |
| 11/5/2025 | 5.63 USD |
| 11/4/2025 | 5.42 USD |
| 11/3/2025 | 5.74 USD |
| 10/31/2025 | 5.91 USD |
| 10/30/2025 | 5.80 USD |
| 10/29/2025 | 6.12 USD |
| 10/28/2025 | 6.15 USD |
| 10/27/2025 | 6.14 USD |
| 10/24/2025 | 6.30 USD |
| 10/23/2025 | 6.23 USD |
| 10/22/2025 | 6.15 USD |
| 10/21/2025 | 6.17 USD |
| 10/20/2025 | 6.22 USD |
| 10/17/2025 | 6.08 USD |
| 10/16/2025 | 6.43 USD |
| 10/15/2025 | 6.43 USD |
| 10/14/2025 | 6.35 USD |
| 10/13/2025 | 6.15 USD |
| 10/10/2025 | 6.17 USD |
| 10/9/2025 | 6.54 USD |
| 10/8/2025 | 6.64 USD |
| 10/7/2025 | 6.63 USD |
| 10/6/2025 | 6.94 USD |
| 10/3/2025 | 6.97 USD |
| 10/2/2025 | 6.92 USD |
| 10/1/2025 | 6.75 USD |
| 9/30/2025 | 6.79 USD |
| 9/29/2025 | 6.44 USD |
| 9/26/2025 | 6.43 USD |
| 9/25/2025 | 6.22 USD |
| 9/24/2025 | 6.40 USD |
| 9/23/2025 | 6.32 USD |
| 9/22/2025 | 6.55 USD |
| 9/19/2025 | 6.36 USD |
| 9/18/2025 | 6.43 USD |
| 9/17/2025 | 6.08 USD |
| 9/16/2025 | 6.01 USD |
| 9/15/2025 | 5.83 USD |
| 9/12/2025 | 5.80 USD |
| 9/11/2025 | 5.89 USD |
| 9/10/2025 | 5.95 USD |
| 9/9/2025 | 6.08 USD |
| 9/8/2025 | 6.15 USD |
| 9/5/2025 | 6.06 USD |
| 9/4/2025 | 6.28 USD |
| 9/3/2025 | 6.10 USD |
| 9/2/2025 | 6.17 USD |
| 8/29/2025 | 6.19 USD |
| 8/28/2025 | 6.46 USD |
| 8/27/2025 | 6.41 USD |
| 8/26/2025 | 6.50 USD |
| 8/25/2025 | 6.19 USD |
| 8/22/2025 | 6.33 USD |
| 8/21/2025 | 6.29 USD |
| 8/20/2025 | 6.19 USD |
| 8/19/2025 | 6.11 USD |
| 8/18/2025 | 6.52 USD |
| 8/15/2025 | 6.43 USD |
| 8/14/2025 | 6.60 USD |
| 8/13/2025 | 6.89 USD |
| 8/12/2025 | 6.83 USD |
| 8/11/2025 | 6.72 USD |
| 8/8/2025 | 6.82 USD |
| 8/7/2025 | 6.61 USD |
| 8/6/2025 | 6.53 USD |
| 8/5/2025 | 11.84 USD |
| 8/4/2025 | 12.35 USD |
| 8/1/2025 | 9.94 USD |
| 7/31/2025 | 10.41 USD |
| 7/30/2025 | 10.09 USD |
| 7/29/2025 | 10.20 USD |
| 7/28/2025 | 10.87 USD |
| 7/25/2025 | 10.69 USD |
| 7/24/2025 | 10.67 USD |
| 7/23/2025 | 10.85 USD |
| 7/22/2025 | 10.36 USD |
LifeMD Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeMD Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 1.00 | 5.00 | 3.00 | 8.00 | 12.00 | 37.00 | 92.00 | 119.00 | 152.00 | 212.00 | 241.00 | 228.00 | 268.00 | 237.00 |
| – | – | – | 400.00 | -40.00 | 166.67 | 50.00 | 208.33 | 148.65 | 29.35 | 27.73 | 39.47 | 13.68 | -5.39 | 17.54 | -11.57 |
| – | – | 100.00 | 60.00 | 66.67 | 75.00 | 75.00 | 75.68 | 80.43 | 84.03 | 87.50 | 88.68 | 88.68 | 88.68 | 88.68 | 88.68 |
| 188.00 | 188.00 | 1.00 | 3.00 | 2.00 | 6.00 | 9.00 | 28.00 | 74.00 | 100.00 | 133.00 | 188.00 | 213.72 | 202.19 | 237.66 | 210.17 |
| – | – | – | -1.00 | -1.00 | -2.00 | -2.00 | -57.00 | -54.00 | -34.00 | -14.00 | -16.00 | -2.00 | -6.00 | 4.00 | 4.00 |
| – | – | – | -20.00 | -33.33 | -25.00 | -16.67 | -154.05 | -58.70 | -28.57 | -9.21 | -7.55 | -0.83 | -2.63 | 1.49 | 1.69 |
| – | – | – | -1.00 | -1.00 | -1.00 | -3.00 | -63.00 | -61.00 | -48.00 | -23.00 | -21.00 | -10.00 | -3.00 | 11.00 | – |
| – | – | – | – | – | – | 200.00 | 2,000.00 | -3.17 | -21.31 | -52.08 | -8.70 | -52.38 | -70.00 | -466.67 | – |
| 5.90 | 6.10 | 6.20 | 6.70 | 8.30 | 8.80 | 9.90 | 14.30 | 27.00 | 31.00 | 33.91 | 41.20 | 41.20 | 41.20 | 41.20 | 41.20 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales LifeMD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue LifeMD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare LifeMD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares LifeMD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against LifeMD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
LifeMD stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeMD Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeMD business model & stock analysis
LifeMD SWOT Analysis
Strengths
LifeMD Inc has a strong online presence, with a well-established brand and a large customer base. The company offers a wide range of telehealth services, which allows for convenient and accessible healthcare for patients. This provides a competitive edge in the market.
The company's proprietary technology platform enables seamless communication between healthcare providers and patients, enhancing the efficiency of consultations and ensuring personalized care.
LifeMD Inc has a team of highly skilled and experienced healthcare professionals who provide quality medical guidance and treatment to patients. This expertise contributes to the company's reputation as a trusted provider of telehealth services.
Weaknesses
One of the weaknesses of LifeMD Inc is its dependence on technology and internet connectivity. Any technical disruptions or network issues may hinder the delivery of telehealth services, resulting in potential dissatisfaction among customers.
The company's reliance on virtual consultations may limit the scope of physical examinations and diagnostic tests, which could affect the accuracy of diagnoses and treatment plans.
LifeMD Inc may face challenges in attracting and retaining healthcare professionals due to the remote nature of telehealth services. This may impact the availability and accessibility of medical expertise for patients.
Opportunities
The growing demand for telehealth services presents significant opportunities for LifeMD Inc to expand its customer base and increase revenue. The convenience and cost-effectiveness of remote consultations appeal to patients seeking quick and hassle-free healthcare solutions.
LifeMD Inc has the potential to tap into underserved markets or areas with limited access to traditional healthcare facilities. By providing telehealth services, the company can bridge the healthcare gap and reach individuals living in remote or rural locations.
The advancement of technology and increasing acceptance of virtual healthcare consultations in the medical industry create a favorable environment for the growth and development of LifeMD Inc's telehealth services.
Threats
LifeMD Inc faces competition from other telehealth providers in the market. This requires continuous innovation and differentiation to stand out and maintain a competitive advantage.
Regulatory changes and limitations imposed on telehealth services could impact the operations and profitability of LifeMD Inc. Complying with evolving healthcare laws and regulations is crucial to ensure continued legal operation.
Cybersecurity threats and data privacy concerns pose risks to LifeMD Inc and its customers. Protecting sensitive patient information and maintaining secure digital platforms are priorities to maintain trust and credibility.
LifeMD Segments
LifeMD Revenue by Segment (1/3)
3 Years
Max
Details
LifeMD Revenue by Segment (2/3)
3 Years
Max
Details
LifeMD Revenue by Segment (3/3)
3 Years
Max
Details
LifeMD Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
LifeMD historical P/E ratio, EBIT multiple, and P/S ratio
LifeMD annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
LifeMD shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
LifeMD stock splits
Current LifeMD forecasts and price targets in July 2026
Analyst Price Targets 2026| Δ MOM Price Target | 0.00 % |
| Buy | 85.71 % (12) |
| Hold | 14.29 % (2) |
| Sell | 0.00 % (0) |
| 12M Price Target | 8.67 |
| Last Price | 4.32 |
| Currency | USD |
| 12M Return Potential | 100.69 % |
| LTM Return | 0 % |
LifeMD Earnings Estimates
| Date | EPS estimate | Revenue Estimate | Quarterly report |
|---|---|---|---|
| 8/6/2026 | -0.15USD | 50.14 MUSD | 2026 Q2 |
| 8/3/2026 | -0.15USD | 50.14 MUSD | 2026 Q2 |
| 5/8/2026 | -0.23USD | 49.82 MUSD | 2026 Q1 |
| 5/4/2026 | -0.23USD | 49.82 MUSD | 2026 Q1 |
| 3/16/2026 | -0.03USD | 49.54 MUSD | 2025 Q4 |
| 3/9/2026 | -0.03USD | 49.54 MUSD | 2025 Q4 |
| 11/17/2025 | -0.05USD | 63.31 MUSD | 2025 Q3 |
| 11/6/2024 | -0.06USD | 49.62 MUSD | 2024 Q3 |
| 5/10/2024 | -0.13USD | 43.14 MUSD | 2024 Q1 |
| 3/20/2024 | -0.14USD | 41.23 MUSD | 2023 Q4 |
EESG©
Eulerpool ESG Scorecard© for the LifeMD stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
LifeMD shareholder structure
| % | Name |
|---|---|
5.92795% | |
5.00443% | |
4.33345% | |
3.70845% | |
2.53387% | |
2.36590% |
LifeMD Executives and Management Board
Mr. Marc Benathen
(45)Chief Financial Officer
Mr. Nicholas Alvarez
(33)Chief Acquisition Officer
Mr. Stefan Galluppi
(38)Chief Innovation Officer · since 2017
Mr. Dennis Wijnker
(49)Chief Technology Officer
Mr. William Febbo
(56)Director
Frequently asked questions about LifeMD
LifeMD Inc is a leading telehealth company that focuses on providing customized and convenient healthcare solutions to its customers. The business model of LifeMD Inc revolves around offering telemedicine consultations, prescription medications, and direct-to-consumer laboratory testing services. By leveraging advanced technology and a team of experienced healthcare professionals, LifeMD Inc aims to improve access to high-quality healthcare for individuals seeking personalized treatment options.
LifeMD stock
LifeMD Peer Group
LifeMD Ticker
LifeMD FIGI
All fundamentals and in-depth analysis of LifeMD
Our stock analysis for LifeMD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LifeMD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.